Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disordersLisa Ewans, Tony Roscioli, Corrina Walsh et al.|Genetics in Medicine|2018Cited by 200
Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectivenessElizabeth E. Palmer, Rani Sachdev, Deborah Schofield et al.|Molecular Genetics & Genomic Medicine|2018Cited by 115
Development and validation of a targeted gene sequencing panel for application to disparate cancersMark J. McCabe, Manisha Chauhan, Chia-Ling Chan et al.|Scientific Reports|2019Cited by 32